0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-23.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-78.76%
Negative EBIT growth while 0425.HK is at 19.32%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-78.76%
Negative operating income growth while 0425.HK is at 19.32%. Joel Greenblatt would press for urgent turnaround measures.
-98.53%
Negative net income growth while 0425.HK stands at 5.26%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-98.40%
Negative EPS growth while 0425.HK is at 5.48%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-98.40%
Negative diluted EPS growth while 0425.HK is at 5.48%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.03%
Share count expansion well above 0425.HK's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.00%
Diluted share reduction more than 1.5x 0425.HK's 0.00%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
457531.89%
Dividend growth of 457531.89% while 0425.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
40.99%
OCF growth above 1.5x 0425.HK's 6.62%. David Dodd would confirm a clear edge in underlying cash generation.
40.27%
Positive FCF growth while 0425.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-67.49%
Negative 10Y revenue/share CAGR while 0425.HK stands at 272.40%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.33%
Negative 5Y CAGR while 0425.HK stands at 63.15%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-28.41%
Negative 3Y CAGR while 0425.HK stands at 101.85%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1697.85%
Negative 10Y OCF/share CAGR while 0425.HK stands at 700.22%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-72.92%
Negative 5Y OCF/share CAGR while 0425.HK is at 52.22%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.00%
3Y OCF/share CAGR under 50% of 0425.HK's 182.44%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-98.53%
Negative 10Y net income/share CAGR while 0425.HK is at 67.97%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-96.55%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
100.61%
3Y net income/share CAGR 50-75% of 0425.HK's 140.94%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
38.18%
Below 50% of 0425.HK's 137.31%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
39.20%
5Y equity/share CAGR is in line with 0425.HK's 40.78%. Walter Schloss would see parallel mid-term profitability and retention policies.
20.11%
3Y equity/share CAGR at 75-90% of 0425.HK's 24.26%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-19.39%
Cut dividends over 10 years while 0425.HK stands at 71.25%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-55.55%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Firm’s AR is declining while 0425.HK shows 2.16%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-10.88%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.46%
Asset growth well under 50% of 0425.HK's 6.52%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.69%
Under 50% of 0425.HK's 2.24%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.75%
We’re deleveraging while 0425.HK stands at 16.35%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.46%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-13.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.